Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: Description of 20 cases and recommendations based on the literature;Profylactische thyreoïdectomie bij kinderen die drager zijn van een mutatie van multipele endocriene neoplasie type 2: Beschrijving van 20 casussen en aanbevelingen op grond van de literatuur

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 6, 2006, Pages 311-318

  De Groot, J W B ^a   Links, T P ^a   Rouwe, C W ^a   Van Der Wal, J E ^a   Hofstra, R M W ^a   Plukker, J T M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET;

CELL HYPERPLASIA; DISEASE COURSE; DISEASE FREE SURVIVAL; FOLLOW UP; GENE MUTATION; GENE REARRANGEMENT; GENETIC TRANSFECTION; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; HYPOPARATHYROIDISM; LYMPH NODE METASTASIS; NECK DISSECTION; POSTOPERATIVE COMPLICATION; REVIEW; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; CALCITONIN; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; INFANT; LYMPH NODE EXCISION; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PROTO-ONCOGENE PROTEINS C-RET; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 32844472474     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Orlandi F, Caraci P, Mussa A, Saggiorato E, Pancani G, Angeli A. Treatment of medullary thyroid carcinoma: an update. Endocr Relat Cancer. 2001;8:135-47.
2. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 1994;367:375-6.
3. Hofstra RMW, Luijt RB van der, Lips CJM. Van gen naar ziekte; van het RET-gen naar multipele endocriene neoplasie type 2A en 2B, sporadisch en familiair medullair schildkliercarcinoom, ziekte van Hirschsprung en papillair schildkliercarcinoom. Ned Tijdschr Geneeskd. 2001;145:2217-21.
4. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 1993;363:458-60.
5. O'Riordain DS, O'Brien T, Weaver AL, Gharib H, Hay ID, Grant CS, et al. Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B. Surgery. 1994;116:1017-23.
6. Machens A, Ukkat J, Brauckhoff M, Gimm O, Dralle H. Advances in the management of hereditary medullary thyroid cancer. J Intern Med. 2005;257:50-9.
7. Jimenez C, Dang GT, Schultz PN, El-Naggar A, Shapiro S, Barnes EA, et al. A novel point mutation of the RET protooncogene involving the second intracellular tyrosine kinase domain in a family with medullary thyroid carcinoma. J Clin Endocrinol Metab. 2004;89:3521-6.
8. Da Silva AM, Maciel RM, da Silva MR, Toledo SR, de Carvalho MB, Cerutti JM. A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. J Clin Endocrinol Metab. 2003;88:5438-43.
9. Rey JM, Brouillet JP, Fonteneau-Allaire J, Boneu A, Bastie D, Maudelonde T, et al. Novel germline RET mutation segregating with papillary thyroid carcinomas. Genes Chromosomes Cancer. 2001;32: 390-1.
10. Wiench M, Wygoda Z, Gubala E, Wloch J, Lisowska K, Krassowski J, et al. Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients. J Clin Oncol. 2001;19:1374-80.
11. Ahmed SA, Snow-Bailey K, Highsmith WE, Sun W, Fenwick RG, Mao R. Nine novel germline gene variants in the RET proto-oncogene identified in twelve unrelated cases. J Mol Diagn. 2005;7:283-8.
12. Miyauchi A, Matsuzuka F, Hirai K, Yokozawa T, Kobayashi K, Ito Y, et al. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations. World J Surg. 2002;26:1023-8.
13. Demeester R, Parma J, Cochaux P, Vassart G, Abramowicz MJ. A rare variant, 1852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years. Hum Mutat. 2001;17:354.
14. Skinner MA, Moley JA, Dilley WG, Owzar K, Debenedetti MK, Wells Jr SA. Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med. 2005;353:1105-13.
15. Telander RL, Zimmerman D, Heerden JA van, Sizemore GW. Results of early thyroidectomy for medullary thyroid carcinoma in children with multiple endocrine neoplasia type 2. J Pediatr Surg. 1986;21: 1190-4.
16. Lips CJ, Landsvater RM, Hoppener JW, Geerdink RA, Blijham G, Veen JM van, et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med. 1994;331:828-35.
17. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-71.
18. Decker RA, Geiger JD, Cox CE, Mackovjak M, Sarkar M, Peacock ML. Prophylactic surgery for multiple endocrine neoplasia type IIa after genetic diagnosis: is parathyroid transplantation indicated? World J Surg. 1996;20:814-20.
19. Dralle H, Gimm O, Simon D, Frank-Raue K, Gortz G, Niederle B, et al. Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg. 1998;22:744-50.
20. Wells jr SA, Skinner MA. Prophylactic thyroidectomy, based on direct genetic testing, in patients at risk for the multiple endocrine neoplasia type 2 syndromes. Exp Clin Endocrinol Diabetes. 1998;106: 29-34.
21. Lallier M, St-Vil D, Giroux M, Huot C, Gaboury L, Oligny L, et al. Prophylactic thyroidectomy for medullary thyroid carcinoma in gene carriers of MEN2 syndrome. J Pediatr Surg. 1998;33:846-8.
22. Arts CHP, Bax NMA, Jansen M, Lips CJM, Vroom ThM, Vroonhoven ThJMV van. Profylactische totale thyreoïdectomie voor multipele endocriene neoplasie type 2A op de kinderleeftijd: eerste ervaringen. Ned Tijdschr Geneeskd. 1999;143:98-104.
23. Niccoli-Sire P, Murat A, Baudin E, Henry JF, Proye C, Bigorgne JC, et al. Early or prophylactic thyroidectomy in MEN 2/FMTC gene carriers: results in 71 thyroidectomized patients. The French Calcitonin Tumours Study Group (GETC). Eur J Endocrinol. 1999;141: 468-74.
24. Sanso GE, Domene HM, Garcia R, Pusiol E, Mondino AK de, Roque M, et al. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers. Cancer. 2002;94:323-30.
25. Kahraman T, Groot JW de, Rouwe C, Hofstra RM, Links TP, Sijmons RH, et al. Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 23. Eur J Surg Oncol. 2003;29: 331-5.
26. Nusynowitz ML, Pollard E, Benedetto AR, Lecklitner ML, Ware RW. Treatment of medullary carcinoma of the thyroid with I-131. J Nucl Med. 1982;23:143-6.
27. Nieuwenhuijzen Kruseman AC, Bussemaker JK, Frolich M. Radio-iodine in the treatment of hereditary medullary carcinoma of the thyroid. J Clin Endocrinol Metab. 1984;59:491-4.
28. Dralle H, Damm I, Scheumann GF, Kotzerke J, Kupsch E, Geerlings H, et al. Compartment-oriented microdissection of regional lymph nodes in medullary thyroid carcinoma. Surg Today. 1994;24:112-21.
29. Robbins KT, Medina JE, Wolfe GT, Levine PA, Sessions RB, Pruet CW. Standardizing neck dissection terminology. Official report of the Academy's Committee for Head and Neck Surgery and Oncology. Arch Otolaryngol Head Neck Surg. 1991;117:601-5.
30. Machens A. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med. 2003;350:943.
31. Rey JM, Brouillet JP, Fonteneau-Allaire J, Boneu A, Bastie D, Maudelonde T, et al. Novel germline RET mutation segregating with papillary thyroid carcinomas. Genes Chromosomes Cancer. 2001;32:390-1.
32. Peczkowska M, Januszewicz A. Multiple endocrine neoplasia type 2. Fam Cancer. 2005;4:25-36.
33. Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998;228:320-30.
34. Brauckhoff M, Gimm O, Weiss CL, Ukkat J, Sekulla C, Brauckhoff K, et al. Multiple endocrine neoplasia 26 syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease. World J Surg. 2004;28:1305-11.